Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.76
Delayed Data
As of Mar 27
 +0.0107 / +1.43%
Today’s Change
0.72
Today|||52-Week Range
4.73
-52.50%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.75
Today’s open0.81
Day’s range0.72 - 0.87
Volume2,141,784
Average volume (3 months)546,295
Market cap$16.1M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+49.47%
Earnings growth (this year)+72.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+311.34%
P/E ratioNM
Price/Sales74.60
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
ICCCImmuCell Corp-0.09-1.29%
RGBPRegen BioPharma Inc+0.01+5.41%
CMXCCell MedX Corp+0.01+3.70%
CBMXCombiMatrix Corp-0.01-0.50%
Data as of 3:59pm ET, 03/27/2015

Financials

Next reporting dateMarch 31, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$399.0K
Annual profit (last year)-$20.9M
Net profit margin-5,244.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Westborough, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account